Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tectonic Therapeutic (TECX) Other Accumulated Expenses (2017 - 2024)

Tectonic Therapeutic (TECX) has 8 years of Other Accumulated Expenses data on record, last reported at $330000.0 in Q1 2024.

  • On a quarterly basis, Other Accumulated Expenses rose 62.56% to $330000.0 in Q1 2024 year-over-year; TTM through Mar 2024 was $330000.0, a 62.56% increase, with the full-year FY2023 number at $383000.0, up 81.52% from a year prior.
  • Other Accumulated Expenses reached $330000.0 in Q1 2024 per TECX's latest filing, down from $383000.0 in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for TECX hit a ceiling of $1.2 million in Q3 2021 and a floor of $1000.0 in Q3 2023.
  • A 5-year average of $343764.7 and a median of $211000.0 in 2022 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: surged 519.9% in 2021, then crashed 99.76% in 2023.
  • Tracing TECX's Other Accumulated Expenses over 5 years: stood at $348000.0 in 2020, then plummeted by 48.85% to $178000.0 in 2021, then grew by 18.54% to $211000.0 in 2022, then surged by 81.52% to $383000.0 in 2023, then decreased by 13.84% to $330000.0 in 2024.
  • Business Quant data shows Other Accumulated Expenses for TECX at $330000.0 in Q1 2024, $383000.0 in Q4 2023, and $1000.0 in Q3 2023.